Oppenheimer Asset Management Inc. Sells 4,037 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Oppenheimer Asset Management Inc. reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,038 shares of the company’s stock after selling 4,037 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Option Care Health were worth $1,910,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Geneva Capital Management LLC bought a new stake in shares of Option Care Health in the 3rd quarter valued at about $24,679,000. Victory Capital Management Inc. boosted its holdings in shares of Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after purchasing an additional 1,585,818 shares in the last quarter. Atria Investments Inc bought a new position in Option Care Health in the third quarter valued at about $213,000. Villere ST Denis J & Co. LLC increased its position in Option Care Health by 1.3% during the 3rd quarter. Villere ST Denis J & Co. LLC now owns 1,135,106 shares of the company’s stock worth $35,529,000 after purchasing an additional 14,439 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its stake in shares of Option Care Health by 115.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 207,560 shares of the company’s stock valued at $6,497,000 after acquiring an additional 111,185 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Down 1.2 %

Shares of NASDAQ:OPCH opened at $21.93 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market cap of $3.73 billion, a PE ratio of 18.43, a P/E/G ratio of 2.30 and a beta of 1.32. The stock’s 50-day moving average is $28.62 and its 200 day moving average is $29.38. Option Care Health, Inc. has a 1 year low of $21.64 and a 1 year high of $34.63.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Insiders Place Their Bets

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 69.02 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.